Keybank National Association Astrazeneca PLC Transaction History

Keybank National Association

$25.5 Billion
Q3 2024

A detailed history of Keybank National Association transactions in Astrazeneca PLC stock. As of the latest transaction made, Keybank National Association holds 47,208 shares of AZN stock, worth $3.13 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

47,208

Previous 46,893 0.67%

Holding current value

$3.13 Million

Previous $3.66 Million 0.57%

% of portfolio

0.01%

Previous 0.02%

32 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 31, 2024	BUY	$76.67 - $87.62 $24,151 - $27,600	315 Added 0.67%	47,208 $3.68 Million
Q2 2024 Jul 31, 2024	BUY	$66.81 - $80.83 $1,068 - $1,293	16 Added 0.03%	46,893 $3.66 Million
Q1 2024 May 14, 2024	SELL	$61.03 - $69.57 $430,261 - $490,468	-7,050 Reduced 13.07%	46,877 $3.18 Million
Q4 2023 Feb 13, 2024	BUY	$61.89 - $69.28 $92,030 - $103,019	1,487 Added 2.84%	53,927 $3.63 Million
Q3 2023 Nov 08, 2023	BUY	$64.85 - $71.7 $3,307 - $3,656	51 Added 0.1%	52,440 $3.55 Million
Q2 2023 Aug 01, 2023	SELL	$69.91 - $75.81 $956,298 - $1.04 Million	-13,679 Reduced 20.7%	52,389 $3.75 Million
Q1 2023 May 10, 2023	SELL	$63.15 - $71.6 $38,837 - $44,034	-615 Reduced 0.92%	66,068 $4.59 Million
Q4 2022 Jan 31, 2023	BUY	$54.21 - $70.44 $144,903 - $188,286	2,673 Added 4.18%	66,683 $4.52 Million
Q3 2022 Oct 27, 2022	BUY	$53.02 - $135.75 $124,013 - $317,519	2,339 Added 3.79%	64,010 $3.51 Million
Q2 2022 Aug 08, 2022	SELL	$59.26 - $71.14 $79,526 - $95,469	-1,342 Reduced 2.13%	61,671 $4.08 Million
Q1 2022 Apr 28, 2022	SELL	$55.72 - $67.12 $671,147 - $808,460	-12,045 Reduced 16.05%	63,013 $4.18 Million
Q4 2021 Feb 07, 2022	BUY	$54.02 - $63.83 $14,909 - $17,617	276 Added 0.37%	75,058 $4.37 Million
Q3 2021 Nov 08, 2021	BUY	$55.56 - $60.79 $230,462 - $252,156	4,148 Added 5.87%	74,782 $4.49 Million
Q2 2021 Aug 12, 2021	BUY	$48.42 - $60.18 $16,075 - $19,979	332 Added 0.47%	70,634 $4.23 Million
Q1 2021 May 07, 2021	BUY	$47.16 - $54.44 $70,409 - $81,278	1,493 Added 2.17%	70,302 $3.5 Million
Q4 2020 Feb 09, 2021	SELL	$48.52 - $58.02 $13,537 - $16,187	-279 Reduced 0.4%	68,809 $3.44 Million
Q3 2020 Oct 29, 2020	SELL	$53.07 - $61.1 $3,131 - $3,604	-59 Reduced 0.09%	69,088 $3.79 Million
Q2 2020 Aug 10, 2020	BUY	$43.1 - $55.31 $862 - $1,106	20 Added 0.03%	69,147 $3.66 Million
Q1 2020 May 13, 2020	BUY	$37.79 - $51.33 $2,645 - $3,593	70 Added 0.1%	69,127 $3.09 Million
Q4 2019 Feb 05, 2020	BUY	$42.46 - $50.46 $108,273 - $128,673	2,550 Added 3.83%	69,057 $3.44 Million
Q3 2019 Nov 04, 2019	BUY	$40.12 - $45.47 $7,743 - $8,775	193 Added 0.29%	66,507 $2.96 Million
Q2 2019 Aug 01, 2019	BUY	$37.28 - $41.68 $83,842 - $93,738	2,249 Added 3.51%	66,314 $2.74 Million
Q1 2019 May 08, 2019	BUY	$35.49 - $43.02 $198,105 - $240,137	5,582 Added 9.54%	64,065 $2.59 Million
Q4 2018 Jan 30, 2019	BUY	$36.86 - $41.49 $224,846 - $253,089	6,100 Added 11.64%	58,483 $2.22 Million
Q3 2018 Nov 08, 2018	SELL	$34.76 - $39.72 $986,662 - $1.13 Million	-28,385 Reduced 35.14%	52,383 $2.07 Million
Q2 2018 Aug 08, 2018	SELL	$34.55 - $37.05 $6,253 - $6,706	-181 Reduced 0.22%	80,768 $2.84 Million
Q1 2018 May 15, 2018	SELL	$32.97 - $36.63 $37,289 - $41,428	-1,131 Reduced 1.38%	80,949 $2.83 Million
Q4 2017 Feb 08, 2018	BUY	$32.09 - $34.78 $16,558 - $17,946	516 Added 0.63%	82,080 $2.85 Million
Q3 2017 Nov 02, 2017	SELL	$28.96 - $34.0 $68,056 - $79,900	-2,350 Reduced 2.8%	81,564 $2.76 Million
Q2 2017 May 14, 2018	SELL	N/A	-2,120 Reduced 2.46%	83,914 $2.86 Million
Q1 2017 May 14, 2018	BUY	N/A	3,673 Added 4.46%	86,034 $2.68 Million
Q4 2016 May 14, 2018	BUY	N/A	82,361	82,361 $2.25 Million

Others Institutions Holding AZN

# of Institutions

1,361

Shares Held

475M

Call Options Held

5.39M

Put Options Held

3.75M

View Full List

About ASTRAZENECA PLC

Ticker AZN
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 3,099,020,032
Market Cap $205B
Description
AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...

More about AZN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Keybank National Association, based on Form 13F filings with the SEC.

News

Stay updated on Keybank National Association with notifications on news.

Account

Keybank National Association Astrazeneca PLC Transaction History